2000
DOI: 10.1046/j.1365-2133.2000.03596.x
|View full text |Cite
|
Sign up to set email alerts
|

Cytokine profiles in spontaneously regressing basal cell carcinomas

Abstract: These findings support a role for T-helper 1 type cytokines in mediating spontaneous regression of BCCs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
64
0
2

Year Published

2001
2001
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(74 citation statements)
references
References 34 publications
2
64
0
2
Order By: Relevance
“…The spontaneous regression of these as well as of other tumors carries a great therapeutic potential, but the knowledge of the underlying mechanisms remains very limited. In BCC, tumor regression has been associated with cells of the immune system and certain cytokines (4,5), but the understanding of this phenomenon is incomplete.…”
Section: Introductionmentioning
confidence: 99%
“…The spontaneous regression of these as well as of other tumors carries a great therapeutic potential, but the knowledge of the underlying mechanisms remains very limited. In BCC, tumor regression has been associated with cells of the immune system and certain cytokines (4,5), but the understanding of this phenomenon is incomplete.…”
Section: Introductionmentioning
confidence: 99%
“…4 Basal cell carcinoma tends to grow slowly and rarely metastasizes. Additionally, BCC can spontaneously regress, exhibiting a shift in immune response toward a T H 1 profile, 5,6 which See also page 1347 in turn suggests that the immune system plays an active role in BCC surveillance. 4 Immune response in BCC can be modulated by intralesional injections of interferons or by topical application of imiquimod, each resulting in complete clearance of the tumor.…”
mentioning
confidence: 99%
“…Some cases of BCC may show spontaneous regression in the absence of therapy. Such spontaneous regression is mediated by activated CD4+ T cells, and IFN-γ is elevated in actively regressing BCC (28). There is a significantly increased number of CD4+ T cells infiltrating regressing tumors, and the expression of IL-2 receptor, which is an early activation marker for T cells is also increased (29).…”
Section: Ifn-γmentioning
confidence: 87%